AVLN

Conviction 100HealthcareScan · Thu, Jun 25, 2026

AVLN$28.93-3.86%

ResistanceSupportVol 14Insider buy

Vol MA14 494.21K

Apr 30May 12May 21Jun 3Jun 12Jun 25

Avalyn Pharma Inc.Biotechnologywww.avalynpharma.com ↗

Price28.93

Change-3.86%

Gap+0.73%

Rel volume4.27×

Avg volume415.5K

Avg $ vol12.23M

SMA 2028.76

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 34.28

RSI (14)49

MACD hist0.24

MACD cross—

Stoch %K / %D42 / 63

ADX (14)12

+DI / −DI17 / 14

RSI divergence—

MACD divergence—

ATR %+9.85%

ADR %9.73%

52w high32.97

52w low25.72

From 52w high-12.25%

Above 52w low+12.48%

New 52w highNo

SqueezeOn · 1d

Bollinger width25.67%

%B0.52

Donchian pos52.59%

Donchian high33.24

Donchian low24.15

AVWAP (52w high)29.89

vs AVWAP high-3.23%

AVWAP (52w low)29.63

vs AVWAP low-2.36%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d4.27×

Avg vol (14d)494.21K

Avg vol (20d)415.5K

Avg $ vol (20d)12.23M

Market cap1.28B

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank61.8

1 week-1.30%

1 month+8.35%

3 months—

6 months—

1 year—

YTD-1.90%

P/E—

P/B-4.85

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq-0.06

Current11.03

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target52.00

Target upside79.74%

Analyst ratingBuy

Institutional—

Ent. value1.21B

Revenue—

Net income-26.87M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out44.33M

Employees—

ListedThu, Apr 30, 2026

Free float30.62M

Float %73.2%

Short interest896.14K

Days to cover3.2d

Short volume70.4%

Squeeze score57 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$21.83 vs −$16.38

Last surprise-33.3% miss

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank61.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AVLN

All disclosures →

No recent disclosed trades by Congress in AVLN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AVLN · 4 buys · 6 sells

Insider	Side	Shares	Value	Traded	Filed
Novo Holdings A/S 10% owner · Series D Preferred Stock · 2026-05-01	Convert	12.56M	$0	2026-05-01	2026-05-05
FMR LLC 10% owner · Common Stock · 2026-05-01	Convert	80.29K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Common Stock · 2026-05-01	Convert	727.59K	—	2026-05-01	2026-05-05
Novo Holdings A/S 10% owner · Voting Common Stock · 2026-05-01	Buy	555.55K	$10.0M	2026-05-01	2026-05-05
FMR LLC 10% owner · Series A Preferred Stock · 2026-05-01	Convert	727.59K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Series D Preferred Stock · 2026-05-01	Convert	377.95K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Series B Preferred Stock · 2026-05-01	Convert	80.29K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Common Stock · 2026-05-01	Convert	225.84K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Series C-2 Preferred Stock · 2026-05-01	Convert	225.84K	—	2026-05-01	2026-05-05
Novo Holdings A/S 10% owner · Series B Preferred Stock · 2026-05-01	Convert	1.99M	$0	2026-05-01	2026-05-05

SEC filings

EDGAR filings in AVLN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.